BPI West reaches close to the same bioprocessing audience as the Boston shows, but on the West Coast and earlier in the year. For a seller with West Coast biomanufacturing accounts, it is the efficient way to be in the room without the travel cost of the fall Boston week.
What BPI West is
BPI West, part of the BioProcess International series, is a West Coast bioprocessing and biomanufacturing conference covering process development, manufacturing, and analytical work for biologics and advanced therapies. Its audience is weighted toward process development and manufacturing roles at West Coast biotech and pharma, along with the CDMOs, contract manufacturers, and tools vendors that serve biologics and advanced-therapy production. It is a manufacturing and operations audience rather than a clinical or business-development one.
The GTM signal at BPI West
Exhibiting at BPI West reflects a real, budgeted decision to be visible to a manufacturing-specific West Coast audience, the same strongest-signal logic that applies at any show. A named speaker on the agenda is a specific, timely contact-level hook. Because the show is regionally concentrated, presence here is also a useful qualifier on where an account's manufacturing footprint sits, which can sharpen a West-Coast-focused territory plan. See selling around life science conferences for how to weigh exhibiting, presenting, and attending.
The outreach window
Exhibitor and speaker lists become public ahead of the spring show, giving a multi-week window to cross-reference the roster against your West Coast manufacturing account list and plan specific outreach before the doors open. On-site outreach works as a fallback for accounts identified late. The post-show window holds for a few weeks while a reference to a specific conversation is still fresh.
Who this matters most for
A CDMO serving biologics or advanced-therapy manufacturing on the West Coast should treat BPI West as a primary regional show rather than a secondary one. A manufacturing-adjacent tools or services vendor serving bioprocessing workflows will find a close-fit audience without the Boston travel cost. A CRO whose buyer sits in clinical operations will get more direct value from a clinical-focused show.